Krebs Biochemicals & Industries Limited (KREBSBIO.NS) NSE

69.10

+3.82(+5.85%)

Updated at December 05 12:20PM

Currency In INR

Valuation

Market Cap1.46B
Enterprise Value3.58B
P/E Ratio-5.67
PEG Ratio3.96
Price/Sales Ratio5.72
Price/Book Ratio-0.99
Enterprise/Revenue13.76
Enterprise/EBITDA-26.02

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.01
Operating Margin-0.79

Management Effectiveness

Return On Assets-0.16
Return On Equity0.19

Income Statement

Revenue433.12M
Revenue/Share12.62
Gross Profit377.56M
EBITDA-143.21M
Net Income-269.39M
Diluted EPS-12.5

Balance Sheet

Total Cash1.27M
Total Cash/Share0.06
Total Debt2.19B
Total Debt/Equity-1.39
Current Ratio0.09
Book Value Per Share-73.15

Price History

52-Week Change-31.41
52-Week High115.8
52-Week Low64.04
Moving Average 50 Days69.28
Moving Average 200 Days76.46

Statistics

Average Volume9,262
Shares Outstanding21.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor207:200
Last Split DateJanuary 31, 2019